1. Abstract
The Multidimensional AIDS Anxiety Questionnaire (MAAQ), developed by William E. Snell, Jr. and Phillip D. Finney (1989, 1996), is a standardized self-report psychometric instrument designed to assess the multifaceted nature of apprehension, distress, and behavioral inhibition elicited by the Acquired Immune Deficiency Syndrome (HIV/AIDS) epidemic. Comprising 50 items rated on a 5-point Likert-type response format ranging from 0 (not at all characteristic of me) to 4 (very characteristic of me), the questionnaire was engineered to transcend unidimensional conceptualizations of disease-related fear by decomposing the clinical construct into distinct cognitive, somatic, affective, and interpersonal behavioral domains.
Exploratory and confirmatory psychometric evaluations delineate five primary robust factors possessing eigenvalues exceeding unity: (1) Physiological Arousal (16 items), which measures visceral, somatic, and autonomic manifestations of anxiety in response to AIDS-related cues; (2) Fear of AIDS (6 items), capturing acute affective dread, terror, and phobic apprehension regarding personal infection; (3) Sexual Inhibition (6 items), quantifying behavioral avoidance, reluctance, and disruption of sexual intimacy precipitated by transmission fears; (4) Cognitive Worry (5 items), indexing intrusive rumination, preoccupation, and obsessive ideation concerning the epidemic; and (5) Discussion Inhibition (5 items), evaluating communicative avoidance, reticence, and interpersonal embarrassment when addressing AIDS-related topics with intimate partners and peers. A tentative sixth dimension, Anxiety About AIDS Exposure (3 items), captures retrospective preoccupation with past exposure vectors.
Internal consistency metrics demonstrate exceptional reliability across the primary subscales, with Cronbach’s alpha coefficients spanning from .85 to .94. Four-week test-retest reliability estimates range from moderate stability for Cognitive Worry and Discussion Inhibition (r = .40) to substantial temporal stability for Fear of AIDS (r = .78) and Physiological Arousal (r = .65). Convergent, discriminant, and predictive validity studies establish that the MAAQ correlates predictably with general trait anxiety and safe-sex health behaviors—specifically showing that somatic and communicative anxiety patterns uniquely predict proactive prophylactic utilization (e.g., condoms and spermicides) among young adults—while remaining empirically distinguishable from generalized social desirability and relationship-specific anxiety.
2. Keywords
Multidimensional AIDS Anxiety Questionnaire, MAAQ, HIV/AIDS anxiety, health anxiety, sexual inhibition, fear of disease, psychometrics, scale validation, somatic arousal, communicative avoidance
3. Authors
The Multidimensional AIDS Anxiety Questionnaire was conceptualized, operationalized, and psychometrically validated by:
- William E. Snell, Jr., Ph.D. — Professor Emeritus of Psychology, Department of Psychology, Southeast Missouri State University, Cape Girardeau, Missouri, United States. Dr. Snell is widely recognized for his extensive psychometric contributions to health psychology, human sexuality, interpersonal communication, and multidimensional personality assessment. (Correspondence: Department of Psychology, Southeast Missouri State University, One University Plaza, Cape Girardeau, MO 63701; Email: [email protected]).
- Phillip D. Finney, Ph.D. — Professor of Psychology, Department of Psychology, Southeast Missouri State University, Cape Girardeau, Missouri, United States. Dr. Finney has authored numerous research studies focusing on social psychology, attitudes toward chronic illness, cognitive appraisal mechanisms, and quantitative measurement methodologies.
4. Purpose
During the nascent and escalating stages of the global HIV/AIDS pandemic throughout the late 1980s and early 1990s, medical and psychological communities witnessed unprecedented levels of societal dread, stigmatization, and existential panic. While epidemiological research primarily targeted transmission routes and retroviral virology, social scientists lacked a psychometrically nuanced instrument to quantify the psychological toll exerted by the crisis on the broader public. Prior health anxiety inventories typically treated disease-related anxiety as a monolithic, global entity, failing to distinguish between somatic tension, cognitive rumination, sexual decision-making paralysis, and interpersonal communication blocks.
The primary purpose of the MAAQ was to establish a standardized, multidimensional self-report inventory that disaggregates generalized panic surrounding HIV/AIDS into clinically and behaviorally meaningful facets. By differentiating somatic symptoms from cognitive worry and behavioral avoidance, the scale allows clinical psychologists, public health researchers, and epidemiologists to investigate how specific permutations of disease anxiety influence real-world health behaviors, sexual practices, and psychiatric morbidity.
Theoretical Rationale and Behavioral Health Applications
A central theoretical justification for the MAAQ is the complex, non-linear relationship between anxiety and preventative health behaviors. In classic psychological paradigms such as the Health Belief Model and Protection Motivation Theory, perceived threat can serve either as a catalyst for adaptive self-protective action (e.g., obtaining barrier contraception, undergoing diagnostic testing) or as a trigger for maladaptive avoidance, denial, and interpersonal withdrawal. Snell and Finney recognized that unidimensional measures obscured these bifurcated outcomes; individuals who experience acute physiological panic may adopt entirely different coping responses compared to those whose anxiety manifests primarily as communicative inhibition with intimate partners.
In applied clinical and research domains, the MAAQ fulfills multiple diagnostic and investigative functions:
- Preventative Health and Sexual Risk Assessment: It enables researchers to isolate which anxiety profiles predict consistent condom usage, prophylactic compliance, and partner negotiation, versus those that generate cognitive avoidance, fatalism, or behavioral paralysis.
- Targeted Psychoeducational Intervention: Public health communicators can deploy the scale to evaluate baseline community apprehensions, thereby designing educational campaigns that mitigate irrational discussion taboos without extinguishing the adaptive vigilance necessary for disease prevention.
- Clinical Diagnosis and Treatment Planning: Mental health clinicians utilize the instrument to detect specific phobic manifestations (nosophobia / cyberchondria / illness anxiety disorder focused on HIV), differentiating patients who experience acute autonomic arousal from those grappling with retroactive moral panic regarding past sexual contacts.
5. Psychological Construct
The Multidimensional AIDS Anxiety Questionnaire operationalizes AIDS-related anxiety as a multifaceted cognitive, affective, physiological, and behavioral construct. Rather than framing disease anxiety solely as an emotional reaction of diffuse terror, the MAAQ delineates five empirically substantiated primary dimensions and one exploratory dimension:
1. Physiological Arousal
This subscale (comprising 16 items: 13, 14, 23, 27, 28, 29, 31, 33, 34, 38, 39, 43, 44, 46, 47, and 48) measures visceral and autonomic manifestations of anxiety provoked by exposure to AIDS-related stimuli, discussions, or media reporting. Individuals scoring high on this dimension experience elevated sympathetic nervous system reactivity, including tachycardia, muscle tension, restlessness, jitteriness, and feelings of being physically “on edge” or overwhelmed when the topic of HIV/AIDS arises. Exemplar item: “My heart beats fast with anxiety when I think about AIDS” (Item 13).
2. Fear of AIDS
Comprising 6 items (5, 6, 10, 15, 16, and 21), this subscale captures acute affective dread, phobic apprehension, and explicit terror regarding personal vulnerability to contracting HIV/AIDS. High scores reflect an intense, conscious state of alarm concerning the lethal consequences of infection and the perceived immediacy of transmission threats within romantic or sexual contexts. Exemplar item: “I’m afraid of getting AIDS” (Item 6).
3. Sexual Inhibition
Comprising 6 items (18, 30, 35, 37, 40, and 42), this behavioral-affective dimension quantifies the extent to which the specter of AIDS dampens, interrupts, or paralyzes an individual’s sexual agency, libido, and willingness to initiate or participate in romantic/sexual relationships. High-scoring individuals report profound hesitation, apprehension, and avoidance of intimacy due to potential viral contamination. Exemplar item: “Because of AIDS, I feel too nervous to start a new sexual relationship” (Item 42).
4. Cognitive Worry
Comprising 5 items (1, 3, 4, 8, and 9), this cognitive-affective subscale assesses pervasive, recurring rumination, apprehension, and generalized worry centered on the HIV/AIDS epidemic. Unlike the acute panic captured by the Fear dimension, Cognitive Worry represents an ongoing, pervasive cognitive burden characterized by feeling flustered, tense, and mentally unsettled when reflecting on the broader societal epidemic. Exemplar item: “I feel flustered when I realize the threat of AIDS” (Item 8).
5. Discussion Inhibition
Comprising 5 items (2, 7, 12, 19, and 24), this interpersonal-communicative subscale quantifies the social avoidance, embarrassment, shyness, and communicative inhibition individuals experience when discussing HIV/AIDS, safe-sex practices, or sexual history with casual peers or intimate romantic partners. High scores denote severe communication barriers that impede dyadic health negotiations. Exemplar item: “I have trouble talking about AIDS with an intimate partner” (Item 7).
6. Anxiety About AIDS Exposure (Exploratory Subscale)
Comprising 3 items (20, 49, and 50), this exploratory dimension addresses retroactive health anxiety, specifically obsessive ideation and distress regarding whether historical sexual partners may have transmitted the virus, or persistent fears that one is an asymptomatic carrier. Exemplar item: “I sometimes worry that one of my past sexual partners may have had AIDS” (Item 20).
6. Theoretical Framework
The structural composition of the MAAQ is firmly rooted in classical cognitive-behavioral theories of anxiety (e.g., Aaron T. Beck, Peter Lang) and contemporary health behavior models. Peter Lang’s foundational Three-Systems Model of Fear and Anxiety posits that emotional distress does not operate as a uniform psychological state, but rather manifests across three loosely coupled response systems: (a) the verbal-cognitive system (intrusive worry, catastrophic thoughts, appraisals of threat), (b) the physiological-somatic system (sympathetic nervous system activation, hyperarousal, visceral tension), and (c) the overt behavioral system (escape, avoidance, motor inhibition). The MAAQ explicitly mirrors this triadic framework by operationalizing cognitive worry, physiological arousal, and behavioral avoidance (manifested as sexual and communicative inhibition) into independent yet interrelated measurement axes.
Furthermore, the scale integrates principles from Richard Lazarus and Susan Folkman’s Transactional Model of Stress and Coping. According to transactional theory, the psychological impact of a health stressor is mediated by an individual’s primary appraisal (evaluating the pathogen as lethal, catastrophic, or personally threatening) and secondary appraisal (evaluating one’s behavioral coping resources, such as personal communication self-efficacy or condom accessibility). When secondary coping mechanisms are perceived as inadequate or socially fraught, primary threat appraisals evolve into debilitating anxiety that impedes interpersonal dialogue (Discussion Inhibition) and leads to behavioral withdrawal (Sexual Inhibition).
Additionally, the MAAQ draws from Albert Bandura’s Social Cognitive Theory, particularly the construct of communicative self-efficacy. Sexual risk reduction is fundamentally an interpersonal, dyadic negotiation. If an individual harbors excessive social evaluative anxiety or communicative apprehension regarding sex and disease, the resulting discussion inhibition undermines preventive self-efficacy, paradoxically elevating real-world epidemiological vulnerability despite elevated subjective fear.
7. Validity
The psychometric validity of the MAAQ has been established through extensive construct, convergent, discriminant, and predictive validation protocols conducted across clinical and normative university cohorts (Finney & Snell, 1989; Snell & Finney, 1996).
Construct and Factorial Validity
Factor-analytic procedures (detailed in Section 9) confirmed that the 50 items cluster into distinct psychological dimensions rather than a general, diffuse distress factor. The emergence of five discrete factors accounting for substantial cumulative variance supports the multidimensional construct conceptualization, confirming that physiological reactivity operates independently from social-communicative inhibition and cognitive rumination.
Convergent and Discriminant Validity
To assess convergent validity, Snell and Finney correlated the MAAQ subscales with validated psychometric measures of general trait anxiety, social evaluative fear, and relationship distress:
- General Anxiety Convergence: The MAAQ subscales demonstrated statistically significant, moderate positive correlations with validated inventories of generalized trait anxiety, confirming that individuals with higher baseline neuroticism and somatic reactivity exhibit greater baseline susceptibility to disease-related panic.
- Domain-Specific Discriminant Validity: Discriminant validity was established by evaluating correlations between the MAAQ and specific relationship anxiety measures. While generalized anxiety was broadly associated with the MAAQ, relationship-specific anxieties failed to correlate significantly with the physiological arousal and fear subscales, indicating that the MAAQ measures pathogen-specific health threat rather than pervasive interpersonal insecurity.
- Independence from Social Desirability: Correlations between the MAAQ subscales and the Marlowe-Crowne Social Desirability Scale were non-significant, confirming that self-reported sexual inhibition, discussion avoidance, and somatic panic are not contaminated by impression management or socially desirable responding.
- Construct Alignment with Related Scales: The MAAQ exhibited predictable, robust convergent associations with the Stereotypes About AIDS Scale (Snell, Finney, & Godwin, 1991) and the AIDS Discussion Strategy Scale (Snell & Finney, 1990), demonstrating that discussion inhibition on the MAAQ correlates strongly with passive, evasive, or manipulative interpersonal strategies when approaching safe-sex dialogues.
Predictive and Behavioral Health Validity
A critical empirical validation of the MAAQ lies in its capacity to predict actual health protective behaviors. Research revealed notable gender-moderated predictive pathways:
- Among young adult males, higher scores on the Physiological Arousal subscale were positively and significantly correlated with reliable, consistent contraceptive behaviors. Elevated somatic anxiety functioned as an affective driver, prompting proactive behavioral adaptations, including self-reported modifications in sexual practices to minimize transmission risks.
- Furthermore, male physiological arousal demonstrated a statistically significant trend toward consistent prophylactic usage, specifically the use of condoms and spermicides. Conversely, individuals scoring high on Discussion Inhibition exhibited lower rates of pre-coital safe-sex communication, illustrating the divergent behavioral pathways captured by the multidimensional framework.
8. Reliability
The reliability of the MAAQ has been substantiated through rigorous assessments of internal consistency and temporal test-retest stability.
Internal Consistency
Internal consistency analyses conducted by Finney and Snell (1989) on the primary validation cohort revealed exceptional homogeneity across the established subscales. Cronbach’s alpha coefficients for the five primary factors were as follows:
- Physiological Arousal: α = .94 (indicating robust item covariance across its 16 somatic and visceral indicators).
- Fear of AIDS: α = .88 (reflecting high internal coherence among acute fear items).
- Sexual Inhibition: α = .86 (demonstrating consistent measurement of sexual behavioral reluctance).
- Cognitive Worry: α = .85 (indicating strong internal consistency for pervasive rumination items).
- Discussion Inhibition: α = .85 (confirming uniform measurement of interpersonal conversational apprehension).
Across all five primary subscales, the alpha values consistently exceed the accepted psychometric benchmark of .80 for basic research and clinical screening, with the overall instrument demonstrating internal consistency coefficients ranging between .85 and .94.
Test-Retest Stability
Temporal stability evaluations conducted across a multi-week retest interval revealed varying degrees of test-retest reliability, reflecting the differing situational malleability of each psychological dimension:
- Fear of AIDS: r = .78 (high temporal stability, indicating that phobic dread remains stable over time).
- Physiological Arousal: r = .65 (substantial temporal consistency for autonomic reactivity patterns).
- Sexual Inhibition: r = .63 (moderate-to-high temporal stability in sexual behavioral hesitation).
- Cognitive Worry: r = .40 (moderate stability, reflecting the dynamic sensitivity of cognitive worry to external media coverage, news cycles, and recent environmental cues).
- Discussion Inhibition: r = .40 (moderate stability, reflecting communicative anxiety fluctuations depending on changes in relationship status and dyadic familiarity).
9. Factor Analysis
The dimensional architecture of the MAAQ was established through exploratory factor analysis using Principal Components Analysis (PCA) followed by orthogonal Varimax rotation on the original 50-item pool (Finney & Snell, 1989; Snell & Finney, 1996).
Factor Extraction and Variance Distribution
Application of the Kaiser-Guttman criterion (eigenvalues > 1.0) and scree plot examination identified five primary interpretable factors that accounted for the vast majority of common variance:
- Factor 1: Physiological Arousal: Possessed an initial eigenvalue of 17.00, accounting for 34.0% of the total explained variance. This dominant first factor captured 16 items reflecting autonomic hyperactivation, racing heartbeat, physical tension, and somatic distress triggered by AIDS-related thoughts and media coverage.
- Factor 2: Fear of AIDS: Generated an eigenvalue of 4.43, accounting for 8.9% of the total variance. Six items loaded cleanly onto this factor, defining acute terror, fear of infection, and personal vulnerability.
- Factor 3: Sexual Inhibition: Exhibited an eigenvalue of 2.24, explaining 4.5% of the total variance. Six statements concerned with the cessation, hesitation, or avoidance of sexual relations loaded onto this dimension.
- Factor 4: Cognitive Worry: Demonstrated an eigenvalue of 1.23, accounting for 2.5% of the total variance. Five items indexed chronic worry, feeling flustered, and nervous preoccupation regarding the broader epidemic.
- Factor 5: Discussion Inhibition: Yielded an eigenvalue of 1.16, explaining 2.3% of the total variance. Five items reflecting shyness, unease, and reluctance to discuss AIDS with partners and acquaintances loaded uniquely on this factor.
- Factor 6 (Exploratory): Anxiety About AIDS Exposure: A tentative sixth factor consisting of 3 items (20, 49, and 50) reflected retroactive exposure concerns. While its initial eigenvalue was slightly below unity (< 1.0) in the primary extraction, the authors retained its clinical scoring designation due to its substantive content relevance regarding historical transmission anxiety.
The Varimax-rotated factor pattern confirmed simple structure: primary item loadings on designated factors generally exceeded .50, with minimal cross-loadings (< .30 on non-target factors). The remaining non-loading items (e.g., items 11, 17, 22, 25, 26, 32, 36, 41, 45) represent exploratory or reverse-scored control items that did not meet primary factor cut-off criteria in the final 5-factor model but were retained in the full 50-item research protocol.
10. Instrument / Measurement Tool
- Instrument Name: Multidimensional AIDS Anxiety Questionnaire (MAAQ)
- Authors: William E. Snell, Jr., Ph.D., and Phillip D. Finney, Ph.D. (Southeast Missouri State University)
- Publication / Validation Dates: 1989 (Initial validation presentation); 1996 (Standardized instrument publication)
- Construct Measured: Multidimensional anxiety, somatic arousal, cognitive worry, and behavioral/communicative inhibition related to HIV/AIDS
- Administration Format: Self-administered paper-and-pencil or computerized questionnaire
- Target Population: Adolescents, young adults, college populations, and adult clinical or community samples
- Completion Time: Approximately 20 to 25 minutes for the full 50-item inventory
- Item Count: 50 items total
- Response Format: 5-point Likert-type scale scored as follows:
- A = 0: Not at all characteristic of me
- B = 1: Slightly characteristic of me
- C = 2: Somewhat characteristic of me
- D = 3: Moderately characteristic of me
- E = 4: Very characteristic of me
- Subscale Item Allocation:
- Physiological Arousal (16 items): Items 13, 14, 23, 27, 28, 29, 31, 33, 34, 38, 39, 43, 44, 46, 47, 48
- Fear of AIDS (6 items): Items 5, 6, 10, 15, 16, 21
- Sexual Inhibition (6 items): Items 18, 30, 35, 37, 40, 42
- Cognitive Worry (5 items): Items 1, 3, 4, 8, 9
- Discussion Inhibition (5 items): Items 2, 7, 12, 19, 24
- Anxiety About AIDS Exposure (Exploratory, 3 items): Items 20, 49, 50
- Unassigned / Control Items: Items 11, 17, 22, 25, 26, 32, 36, 41, 45 (retained for research context or reverse-scoring evaluation)
- Scoring and Interpretation Procedures:
- Subscale scores are derived by calculating the mean response value of the constituent items for each subscale (sum of subscale item responses divided by the number of subscale items).
- Subscale scores maintain a continuous range from 0.00 to 4.00.
- Higher numerical scores reflect greater levels of anxiety, physiological arousal, or behavioral inhibition within that specific domain.
- Because each subscale captures a conceptually distinct manifestation, subscale scores should be interpreted independently rather than collapsed into an omnibus global score.
11. Permissions & Fee and Test Year
The Multidimensional AIDS Anxiety Questionnaire was initially presented by Phillip D. Finney and William E. Snell, Jr. in 1989 and subsequently documented in formal psychometric manuscripts in 1996. The instrument is considered an open-access psychometric instrument developed for academic, scientific, and non-commercial clinical research. No licensing fees or royalty payments are required for academic research or clinical use.
Researchers wishing to use the MAAQ are requested to cite the original validation papers and maintain the integrity of item phrasing and scoring instructions. Formal correspondence and inquiries regarding instrument utilization or permission may be directed to Dr. William E. Snell, Jr., Department of Psychology, Southeast Missouri State University, One University Plaza, Cape Girardeau, MO 63701 (Email: [email protected]).
12. References
Finney, P. D., & Snell, W. E., Jr. (1989, April). The AIDS Anxiety Scale: Components and correlates [Paper presentation]. Annual Meeting of the Southwestern Psychological Association, Houston, TX, United States.
Snell, W. E., Jr., & Finney, P. D. (1990). Interpersonal strategies associated with the discussion of AIDS. Annals of Sex Research, 3(4), 435–451. https://doi.org/10.1007/BF00849704
Snell, W. E., Jr., Finney, P. D., & Godwin, L. J. (1991). Stereotypes about AIDS. Contemporary Social Psychology, 15(1), 18–38.
Snell, W. E., Jr., & Finney, P. D. (1996). The Multidimensional AIDS Anxiety Questionnaire [Unpublished manuscript]. Department of Psychology, Southeast Missouri State University, Cape Girardeau, MO.
Snell, W. E., Jr., Fisher, T. D., & Walters, A. S. (1993). The Multidimensional Sexuality Questionnaire: An objective self-report measure of psychological tendencies associated with human sexuality. Annals of Sex Research, 6(1), 27–55. https://doi.org/10.1007/BF00849744
13. Items of the Scale
Instructions: The items listed below refer to feelings and reactions that people may experience about the disease AIDS (Acquired Immune Deficiency Syndrome). As such, there are no right or wrong answers, only the individual reactions that people have. We are interested in how typical these feelings and behaviors are of you. To provide your responses, use the following scale to indicate how characteristic the following statements are for you.
A = Not at all characteristic of me. (0)
B = Slightly characteristic of me. (1)
C = Somewhat characteristic of me. (2)
D = Moderately characteristic of me. (3)
E = Very characteristic of me. (4)
Note: Remember to respond to all items, even if you are not completely sure. Also, please be honest in responding to these statements.
- Thinking about AIDS makes me feel anxious.
- I sometimes find it hard to discuss issues dealing with AIDS.
- I feel tense when I think about the threat of AIDS.
- I feel quite anxious about the epidemic of AIDS.
- I feel scared about AIDS when I think about sexual relationships.
- I’m afraid of getting AIDS.
- I have trouble talking about AIDS with an intimate partner.
- I feel flustered when I realize the threat of AIDS.
- The disease AIDS makes me feel nervous and anxious.
- I feel scared when I think about catching AIDS from a sexual partner.
- I’m not worried about getting AIDS.
- I would feel shy discussing AIDS with an intimate partner.
- My heart beats fast with anxiety when I think about AIDS.
- I feel anxious when I talk about AIDS with people.
- Because of AIDS, I feel nervous about initiating sexual relations.
- All these discussions of AIDS leaves me feeling a bit alarmed.
- I would not find it hard to discuss AIDS with an intimate partner.
- AIDS makes me feel jittery about having sex with someone.
- I feel uncomfortable when discussing AIDS.
- I sometimes worry that one of my past sexual partners may have had AIDS.
- Thinking about catching AIDS leaves me feeling concerned.
- I would not hesitate to ask a former sex partner about AIDS-related concerns.
- The issue of AIDS is a very stressful experience for me.
- I feel nervous when I discuss AIDS with another person.
- The threat of getting AIDS makes me feel uneasy about sex.
- I worry about what I should do about AIDS.
- Anxiety about AIDS is beginning to affect my personal relationships.
- In general, the media attention on AIDS makes me feel restless.
- I have feelings of worry when I think about AIDS.
- Were I to have sexual relations, I would worry about getting AIDS.
- All this recent media attention about AIDS leaves me feeling on edge.
- AIDS does not influence my willingness to engage in sexual relationships.
- When I think about AIDS, I feel tense.
- I am more anxious than most people are about the disease AIDS.
- If I were to have sex with someone, I would worry about AIDS.
- I’m pretty indifferent to the idea of catching AIDS.
- I would hesitate to involve myself in a sexual relationship because of AIDS.
- When talking about AIDS with someone, I feel jumpy and high-strung.
- I become really frightened when I think about the threat of AIDS.
- The fear of AIDS makes me feel nervous about engaging in sex.
- The increased chances of being infected with AIDS leaves me feeling troubled.
- Because of AIDS, I feel too nervous to start a new sexual relationship.
- The spread of AIDS is causing me to feel quite a bit of stress.
- I worry that AIDS may directly influence my life.
- I had a better attitude towards sex before the AIDS epidemic.
- I get pretty upset when I think about the possibility of catching AIDS.
- The discussion of AIDS makes me feel uncomfortable.
- All this talk about AIDS has left me feeling strained and tense.
- I’m concerned that I might be carrying the AIDS virus.
- I feel nervous when I think that a past sexual partner could have given me AIDS